Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
H. HUANG. (1996) Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation. International Journal of Radiation Biology 70:2, pages 151-160.
Read now
Read now
Articles from other publishers (49)
Xingnan Zhang, Chenhao Hu, Dezhi Li & Song Liu. (2023) Establishment and characterization of a recurrent malignant peripheral nerve sheath tumor cell line: RsNF. Human Cell.
Crossref
Crossref
Edgar Creus‐Bachiller, Juana Fernández‐Rodríguez, Miriam Magallón‐Lorenz, Sara Ortega‐Bertran, Susana Navas‐Rutete, Cleofe Romagosa, Tulio M. Silva, Maria Pané, Anna Estival, Diana Perez Sidelnikova, Mireia Morell, Helena Mazuelas, Meritxell Carrió, Tereza Lausová, David Reuss, Bernat Gel, Alberto Villanueva, Eduard Serra & Conxi Lázaro. (2023) Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities. Molecular Oncology.
Crossref
Crossref
Suganth Suppiah, Sheila Mansouri, Yasin Mamatjan, Jeffrey C. Liu, Minu M. Bhunia, Vikas Patil, Prisni Rath, Bharati Mehani, Pardeep Heir, Severa Bunda, German L. Velez-Reyes, Olivia Singh, Nazanin Ijad, Neda Pirouzmand, Tatyana Dalcourt, Ying Meng, Shirin Karimi, Qingxia Wei, Farshad Nassiri, Trevor J. Pugh, Gary D. Bader, Kenneth D. Aldape, David A. Largaespada & Gelareh Zadeh. (2023) Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. Nature Communications 14:1.
Crossref
Crossref
Hongyu Zhu, Jan Schuemann, Qixian Zhang & Leo E. Gerweck. (2023) Modeling the impact of tissue oxygen profiles and oxygen depletion parameter uncertainties on biological response and therapeutic benefit of FLASH. Medical Physics.
Crossref
Crossref
Miriam Magallón-Lorenz, Ernest Terribas, Sara Ortega-Bertran, Edgar Creus-Bachiller, Marco Fernández, Gerard Requena, Inma Rosas, Helena Mazuelas, Itziar Uriarte-Arrazola, Alex Negro, Tereza Lausová, Elisabeth Castellanos, Ignacio Blanco, George DeVries, Hiroyuki Kawashima, Eric Legius, Hilde Brems, Viktor Mautner, Lan Kluwe, Nancy Ratner, Margaret Wallace, Juana Fernández-Rodriguez, Conxi Lázaro, Jonathan A. Fletcher, David Reuss, Meritxell Carrió, Bernat Gel & Eduard Serra. (2023) Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis. iScience 26:2, pages 106096.
Crossref
Crossref
Juana Fernández-Rodríguez, Edgar Creus-Bachiller, Xiaohu Zhang, Maria Martínez-Iniesta, Sara Ortega-Bertran, Rajarshi Guha, Craig J. Thomas, Margaret R. Wallace, Cleofe Romagosa, Lourdes Salazar-Huayna, Karlyne M. Reilly, Jaishri O. Blakely, Jordi Serra-Musach, Miguel Angel Pujana, Eduard Serra, Alberto Villanueva, Marc Ferrer & Conxi Lázaro. (2022) A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. Molecular Cancer Therapeutics 21:7, pages 1246-1258.
Crossref
Crossref
Bandarigoda N. Somatilaka, Ali Sadek, Renee M. McKay & Lu Q. Le. (2022) Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene 41:17, pages 2405-2421.
Crossref
Crossref
R. L. Haas, B. G. J. Floot, A. N. Scholten, W. T. A. van der Graaf, W. van Houdt, Y. Schrage, M. van de Ven, J. V. M. G. Bovée, F. van Coevorden & C. Vens. (2021) Cellular Radiosensitivity of Soft Tissue Sarcoma. Radiation Research 196:1.
Crossref
Crossref
Jody Fromm Longo, Stephanie N. Brosius, Iya Znoyko, Victoria A. Alers, Dorea P. Jenkins, Robert C. Wilson, Andrew J. Carroll, Daynna J. Wolff, Kevin A. Roth & Steven L. Carroll. (2021) Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Scientific Reports 11:1.
Crossref
Crossref
Alexander Pemov, Hua Li, William Presley, Margaret R Wallace & David T Miller. (2020) Genetics of human malignant peripheral nerve sheath tumors. Neuro-Oncology Advances 2:Supplement_1, pages i50-i61.
Crossref
Crossref
Juliette Thariat, Thomas Tessonnier, Sylvie Bonvalot, Delphine Lerouge, Hamid Mammar, Stephanie Bolle, Audrey Claren, Florence Duffaud, Claire Alapetite & Guillaume Vogin. (2018) La protonthérapie comme modalité d’irradiation dans les sarcomes des os ou cartilage et des tissus mous, état des lieux en 2018. Bulletin du Cancer 105:9, pages 830-838.
Crossref
Crossref
Xiao‐Xiao Li, Shi‐Jie Zhang, Amy P. Chiu, Lilian H. Lo, Jian Huang, Dewi K. Rowlands, Jinhui Wang & Vincent W. Keng. (2018)
Targeting of
AKT
/
ERK
/
CTNNB
1 by
DAW
22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor
. Cancer Medicine 7:9, pages 4791-4800.
Crossref
Crossref
Matthias Kolberg, Jarle Bruun, Astrid Murumägi, John P. Mpindi, Christian H. Bergsland, Maren Høland, Ina A. Eilertsen, Stine A. Danielsen, Olli Kallioniemi & Ragnhild A. Lothe. (2017)
Drug sensitivity and resistance testing identifies
PLK
1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors
. Molecular Oncology 11:9, pages 1156-1171.
Crossref
Crossref
Christopher D. Graham, Niroop Kaza, Hawley C. Pruitt, Lauren M. Gibson, Barbara J. Klocke, Lalita A. Shevde, Steven L. Carroll & Kevin A. Roth. (2016) BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells. Oncotarget 8:5, pages 8670-8678.
Crossref
Crossref
Jennifer Varin, Laury Poulain, Mikael Hivelin, Patrick Nusbaum, Arnaud Hubas, Ingrid Laurendeau, Laurent Lantieri, Pierre Wolkenstein, Michel Vidaud, Eric Pasmant, Nicolas Chapuis & Béatrice Parfait. (2016) Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells. Oncotarget 7:24, pages 35753-35767.
Crossref
Crossref
Gonzalo Lopez, Kate Lynn J. Bill, Hemant Kumar Bid, Danielle Braggio, Dylan Constantino, Bethany Prudner, Abeba Zewdu, Kara Batte, Dina Lev & Raphael E. Pollock. (2015) HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST). PLOS ONE 10:7, pages e0133302.
Crossref
Crossref
Gunnar Johansson, Po-Chun Peng, Po-Yuan Huang, Hsiung-Fei Chien, Kuo-Tai Hua, Min-Liang Kuo, Chin-Tin Chen & Ming-Jen Lee. (2014) Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden. PLoS ONE 9:12, pages e115916.
Crossref
Crossref
Adrienne L. Watson, Leah K. Anderson, Andrew D. Greeley, Vincent W. KengEric P. Rahrmann, Amanda L. Halfond, Natasha M. Powell, Margaret H. CollinsTilat RizviChristopher L. Moertel, Nancy RatnerDavid A. Largaespada. (2014) Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Oncotarget 5:6, pages 1502-1514.
Crossref
Crossref
Eric Pasmant, Armelle Luscan, Jennifer Varin, Ingrid Laurendeau, Béatrice Parfait & Dominique Vidaud. (2013) Relevance of MPNST cell lines as models for NF1 associated-tumors. Journal of Neuro-Oncology 114:3, pages 353-355.
Crossref
Crossref
Adrienne L. Watson, Eric P. Rahrmann, Branden S. Moriarity, Kwangmin Choi, Caitlin B. Conboy, Andrew D. Greeley, Amanda L. Halfond, Leah K. Anderson, Brian R. Wahl, Vincent W. Keng, Anthony E. Rizzardi, Colleen L. Forster, Margaret H. Collins, Aaron L. Sarver, Margaret R. Wallace, Stephen C. Schmechel, Nancy Ratner & David A. Largaespada. (2013) Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance. Cancer Discovery 3:6, pages 674-689.
Crossref
Crossref
Daochun Sun, Ramsi Haddad, Janice M. Kraniak, Steven D. Horne & Michael A. Tainsky. (2013)
RAS/MEK–Independent Gene Expression Reveals BMP2-Related Malignant Phenotypes in the
Nf1
-Deficient MPNST
. Molecular Cancer Research 11:6, pages 616-627.
Crossref
Crossref
Maren Bradtmöller, Christian Hartmann, Jan Zietsch, Sebastian Jäschke, Victor-F Mautner, Andreas Kurtz, Su-Jin Park, Michael Baier, Anja Harder, David Reuss, Andreas von Deimling, Frank L. Heppner & Nikola Holtkamp. (2012) Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours. PLoS ONE 7:11, pages e47595.
Crossref
Crossref
Matthew Wood, Melissa Rawe, Gunnar Johansson, Shu Pang, Ryan S. Soderquist, Ami V. Patel, Sandra Nelson, William Seibel, Nancy Ratner & Yolanda Sanchez. (2011)
Discovery of a Small Molecule Targeting
IRA2
Deletion in Budding Yeast and Neurofibromin Loss in Malignant Peripheral Nerve Sheath Tumor Cells
. Molecular Cancer Therapeutics 10:9, pages 1740-1750.
Crossref
Crossref
George H. De Vries & Anne I. Boullerne. (2010) Glial Cell Lines: An Overview. Neurochemical Research 35:12, pages 1978-2000.
Crossref
Crossref
Thomas J. Turbyville, Demirkan B. Gürsel, Robert G. Tuskan, Jessica C. Walrath, Claudia A. Lipschultz, Stephen J. Lockett, David F. Wiemer, John A. Beutler & Karlyne M. Reilly. (2010) Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD–Dependent Manner. Molecular Cancer Therapeutics 9:5, pages 1234-1243.
Crossref
Crossref
Jenell M. Eckert, Stephanie J. Byer, Buffie J. Clodfelder-Miller & Steven L. Carroll. (2009) Neuregulin-1β and neuregulin-1α differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells. Glia 57:14, pages 1501-1520.
Crossref
Crossref
Nancy Ratner & Shyra J. Miller. (2006) Model systems for neurofibroma and malignant peripheral nerve sheath tumor. Drug Discovery Today: Disease Models 3:2, pages 175-182.
Crossref
Crossref
Shyra J. Miller, Fatima Rangwala, Jon Williams, Peter Ackerman, Sue Kong, Anil G. Jegga, Sergio Kaiser, Bruce J. Aronow, Silke Frahm, Lan Kluwe, Victor Mautner, Meena Upadhyaya, David Muir, Margaret Wallace, Jussara Hagen, Dawn E. Quelle, Mark A. Watson, Arie Perry, David H. Gutmann & Nancy Ratner. (2006) Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues. Cancer Research 66:5, pages 2584-2591.
Crossref
Crossref
Raymond R. Mattingly, Janice M. Kraniak, Joshua T. Dilworth, Patricia Mathieu, Beverly Bealmear, James E. Nowak, Joyce A. Benjamins, Michael A. Tainsky & John J. ReinersJr.Jr.. (2006) The Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Inhibitor PD184352 (CI-1040) Selectively Induces Apoptosis in Malignant Schwannoma Cell Lines. Journal of Pharmacology and Experimental Therapeutics 316:1, pages 456-465.
Crossref
Crossref
Terakeith Lertsburapa & George H. De Vries. (2004) In vitro studies of pigment epithelium-derived factor in human Schwann cells after treatment with axolemma-enriched fraction. Journal of Neuroscience Research 75:5, pages 624-631.
Crossref
Crossref
Martin Malawer & Paul H. SugarbakerBrian G. Fuller. 2001. Musculoskeletal Cancer Surgery. Musculoskeletal Cancer Surgery
85
133
.
Ghazi Alsbeih, Michael D Story, Moshe H Maor, Fady B Geara & William A Brock. (2003) Chromosomal fragility syndrome and family history of radiosensitivity as indicators for radiotherapy dose modification. Radiotherapy and Oncology 66:3, pages 341-344.
Crossref
Crossref
Johanna Haikonen, Virpi Rantanen, Kirsi Pekkola, Jarmo Kulmala & Reidar Grénman. (2003) Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?. International Journal of Cancer 103:6, pages 784-788.
Crossref
Crossref
D. R. Scoles, V. D. Nguyen, Y. Qin, C.-X. Sun, H. Morrison, D. H. Gutmann & S.-M. Pulst. (2002) Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling. Human Molecular Genetics 11:25, pages 3179-3189.
Crossref
Crossref
Richard A. Britten. 2002. Clinically Relevant Resistance in Cancer Chemotherapy. Clinically Relevant Resistance in Cancer Chemotherapy
285
303
.
John D Fenwick & Alan E Nahum. (2001) Series model volume effects in a population of non-identical patients: how low is low?. Physics in Medicine and Biology 46:7, pages 1815-1834.
Crossref
Crossref
Jeffrey E. DeClue, Sue Heffelfinger, Giovanna Benvenuto, Bo Ling, Shaowei Li, Wen Rui, William C. Vass, David Viskochil & Nancy Ratner. (2000) Epidermal growth factor receptor expression in neurofibromatosis type 1–related tumors and NF1 animal models. Journal of Clinical Investigation 105:9, pages 1233-1241.
Crossref
Crossref
Ghazi Alsbeih, Shawn Malone, Catherine Lochrin, Andre Girard, Bernard Fertil & G.Peter Raaphorst. (2000) Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors. International Journal of Radiation Oncology*Biology*Physics 46:1, pages 143-152.
Crossref
Crossref
G. Alsbeih, S. Malone, L. Grimard & G.P. Raaphorst. (1999) La radiosensibilité in vitro des fibroblastes de la peau peut identifier un groupe de patients ayant des complications dans différents tissus sains après radiothérapie. Cancer/Radiothérapie 3:4, pages 318-324.
Crossref
Crossref
B Stausbøl-Grøn, S M Bentzen, K E Jørgensen, O S Nielsen, T Bundgaard & J Overgaard. (1999) In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data. British Journal of Cancer 79:7-8, pages 1074-1084.
Crossref
Crossref
W. Budach. (1997) Genetische Prädisposition und Strahlenempfindlichkeit von TumorenGenetic predisposition and tumor radiation sensitivity. Strahlentherapie und Onkologie 173:9, pages 469-479.
Crossref
Crossref
Søren M. Bentzen. (1997) Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiotherapy and Oncology 43:2, pages 121-131.
Crossref
Crossref
Fady B. Geara, Lester J. Peters, K. Kian Ang, Adam S. Garden, Susan L. Tucker, Lawrence B. Levy & Barry W. Brown. (1996) Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. International Journal of Radiation Oncology*Biology*Physics 35:3, pages 455-462.
Crossref
Crossref
Lester J. Peters. (1996) Radiation therapy tolerance limits: For one or for all?-Janeway lecture. Cancer 77:11, pages 2379-2385.
Crossref
Crossref
R.A. Britten, A.J. Evans, M.J. Allalunis-Turner, A.J. Franko & R.G. Pearcey. (1996) Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiotherapy and Oncology 39:2, pages 145-153.
Crossref
Crossref
Bernard Gery, Jacques Coppey & John B. Little. (1996) Modulation of clonogenicity, growth, and radiosensitivity of three human epidermoid tumor cell lines by a fibroblastic environment. International Journal of Radiation Oncology*Biology*Physics 34:5, pages 1061-1071.
Crossref
Crossref
SANJAY LOGANI, ANDREW S. CHO, BABER H. ALI, H. RODNEY WITHERS, WILLIAM H. MCBRIDE, KRISTI L. KOZLOV, MICHAEL O. HALL, DAVID A. LEE & BRADLEY R. STRAATSMA. (1995) Single-Dose Compared With Fractionated-Dose Radiation of the OM431 Choroidal Melanoma Cell Line. American Journal of Ophthalmology 120:4, pages 506-510.
Crossref
Crossref
Arno J. Mundt, Azhar Awan, Gregory S. Sibley, Michael Simon, Steven J. Rubin, Brian Samuels, William Wong, Michael Beckett, S. Vijayakumar & Ralph R. Weichselbaum. (1995) Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: Clinical and radiobiological results. International Journal of Radiation Oncology*Biology*Physics 32:4, pages 977-985.
Crossref
Crossref
V. Budach, M. Stuschke & W. Budach. 1995. Soft Tissue Sarcomas in Adults. Soft Tissue Sarcomas in Adults
167
171
.